Observe Medical ASA (DE:OM5A) has released an update.
Observe Medical ASA reports strong uptake of its UnoMeter™ medical devices across the UK and Ireland, with over 30 hospitals in England already using their products since the beginning of 2024. The devices are included in the English and Scottish Urology Frameworks, indicating a robust demand, and are also being introduced to the National Drugs Catalogue in Ireland. The company, known for its focus on enhancing patient outcomes and healthcare efficiency, continues to expand its medtech product offerings globally.
For further insights into DE:OM5A stock, check out TipRanks’ Stock Analysis page.
